-
Making Cancer a Family Affair
Instead of hiding details of her metastatic breast cancer diagnosis from her children, Michelle Audoin opened the door for clear expectations and frank conversations.
by Michelle Audoin
-
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
-
Cancer Care Does Not Move in Straight Lines
Cathy Nobil-Dutton did all the right things to protect her health, but a uterine cancer diagnosis showed her life doesn’t always go as expected.
by Cathy Nobil-Dutton
-
Empowering Pediatric Cancer Patients
After twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.
by Suzanne McBride
-
Finding the ‘Silent Killer’
Strange symptoms led cancer care nurse Eve Spiegel to an ovarian cancer diagnosis.
by Eve Spiegel
-
Making Treatment Decisions
It’s not always clear what to do when cancer progresses. Abigail Johnston shares how she has approached treatment decisions since her metastatic breast cancer diagnosis in 2017.
by Abigail M. Johnston
-
Patient Voices
Read stories about cancer and treatment from the people who are living through it.
-
On Wearing a Brave Face for Myself and Others
A woman living with lung cancer reflects on the contrast between how people see her and how she feels as someone living with metastatic disease.
by Suzanne Adriana Remington
-
A Personal Journey of Thyroid Cancer Treatment
The practical side of cancer treatment and life without a thyroid.
by Carly Flumer
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff